These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 172484

  • 21. Macromolecular dispersion of human plasma low-density lipoproteins in hyperlipoproteinemia.
    Hammond MG, Mengel MC, Warmke GL, Fisher WR.
    Metabolism; 1977 Nov; 26(11):1231-42. PubMed ID: 198626
    [No Abstract] [Full Text] [Related]

  • 22. [The LDL VLDL heparin Ca++ complex and the detectability of hyperlipoproteinemia in mass examination].
    Makurat D.
    Wiad Lek; 1977 Dec 01; 30(23):1797-800. PubMed ID: 203123
    [No Abstract] [Full Text] [Related]

  • 23. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F, Sielski J, Stoll H, Alston N, Gail S.
    PA J; 1976 Dec 01; 6(2):54-9. PubMed ID: 10235781
    [No Abstract] [Full Text] [Related]

  • 24. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP, Drouin P, Mejean L, Lambert D, Debry G.
    Therapie; 1978 Dec 01; 33(5):615-22. PubMed ID: 217121
    [No Abstract] [Full Text] [Related]

  • 25. [Hyperlipoproteinemias and their skin manifestations].
    Zabel R.
    Padiatr Grenzgeb; 1974 Dec 01; 13(2-3):99-107. PubMed ID: 4369584
    [No Abstract] [Full Text] [Related]

  • 26. [Differential diagnosis of hyperlipoproteinemia using simultaneous determination of the lipids of the beta-prebeta lipoprotein group and of the lipid (beta and pre-beta)-cholesterol ratio].
    Girard ML, Delattre J, Legrand A, Canal J.
    Ann Biol Clin (Paris); 1973 Dec 01; 31(2):91-3. PubMed ID: 4356118
    [No Abstract] [Full Text] [Related]

  • 27. [Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III].
    Augustin J, Geursen R, Wieland H, Klose G, Greten H.
    Verh Dtsch Ges Inn Med; 1973 Dec 01; 83():387-9. PubMed ID: 206056
    [No Abstract] [Full Text] [Related]

  • 28. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1973 Dec 01; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 29. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H.
    Clin Genet; 1979 Jan 01; 15(1):37-62. PubMed ID: 215360
    [Abstract] [Full Text] [Related]

  • 30. [Relationship between the activity of lecithin cholesterol acyltransferase, hyperlipoproteinemia type and the indicators of the system of hemostasis in chronic ischemic heart disease].
    Furkalo NK, Bol'shakova RM, Solovtsova KM, Mkhitarian LS, Progonnaia VV.
    Vrach Delo; 1978 Dec 01; (12):33-8. PubMed ID: 217177
    [No Abstract] [Full Text] [Related]

  • 31. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD, Strunz CM, Forti N, Credidio Rde A, Diament J, Dereviacki BE, de Góis JM, de Serro-Azul LG.
    Arq Bras Cardiol; 1986 May 01; 46(5):307-10. PubMed ID: 3471185
    [No Abstract] [Full Text] [Related]

  • 32. The beta-lipoprotein doublet in type 3 hyperlipoproteinemia.
    Papadopoulos NK, Herbert PN.
    Clin Chem; 1977 Jun 01; 23(6):978-81. PubMed ID: 192490
    [Abstract] [Full Text] [Related]

  • 33. Triton induced hyperlipoproteinemia in rhesus monkeys.
    Kapoor NK, Nityanand S.
    Indian J Exp Biol; 1975 Mar 01; 13(2):189-90. PubMed ID: 172443
    [No Abstract] [Full Text] [Related]

  • 34. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
    Utermann G, Jaeschke M, Menzel J.
    FEBS Lett; 1975 Aug 15; 56(2):352-5. PubMed ID: 169165
    [No Abstract] [Full Text] [Related]

  • 35. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
    Dunnigan MG, Cochrane MA, Kelly A, Scott JW.
    Q J Med; 1974 Jan 15; 43(169):33-48. PubMed ID: 4362786
    [No Abstract] [Full Text] [Related]

  • 36. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
    Wallentin L, Angelin B, Einarsson K, Leijd B.
    Scand J Clin Lab Invest Suppl; 1978 Jan 15; 150():103-10. PubMed ID: 218268
    [No Abstract] [Full Text] [Related]

  • 37. Achilles tendinitis and tenosynovitis. A diagnostic manifestation of familial type II hyperlipoproteinemia in children.
    Shapiro JR, Fallat RW, Tsang RC, Glueck CJ.
    Am J Dis Child; 1974 Oct 15; 128(4):486-90. PubMed ID: 4369742
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of bezafibrate on disorders of lipid metabolism].
    Stryjek-Kamińska D, Ilińska-Debniak K, Bartosiewicz W, Szczepanik Z.
    Pol Tyg Lek; 1983 Dec 12; 38(50):1567-71. PubMed ID: 6379618
    [No Abstract] [Full Text] [Related]

  • 39. [Densitometric analysis of plasma lipoproteins on cellulose polyacetate. Study of 2132 electrophoretic lipoprotidograms from normolipemic subjects. I].
    Giacchi M, Lungarella G, Bertelli E.
    Boll Soc Ital Biol Sper; 1977 Sep 15; 53(17):1391-7. PubMed ID: 204318
    [No Abstract] [Full Text] [Related]

  • 40. [Diet therapy in hyperlipoproteinemias].
    Canzler H.
    Z Allgemeinmed; 1974 Jan 20; 50(2):53-61. PubMed ID: 4361378
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.